WallStSmart
HIMS

Hims Hers Health Inc

NYSE: HIMS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$26.33
-5.66% today

Updated 2026-04-29

Market cap
$6.08B
P/E ratio
51.63
P/S ratio
2.59x
EPS (TTM)
$0.51
Dividend yield
52W range
$14 – $70
Volume
38.8M

Hims Hers Health Inc (HIMS) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$26.68M$82.56M$148.76M$271.88M$526.92M$872.00M$1.48B$2.35B
Revenue growth (YoY)+209.4%+80.2%+82.8%+93.8%+65.5%+69.3%+59.0%
Cost of revenue$18.88M$37.95M$39.31M$67.38M$118.19M$157.05M$303.38M$614.26M
Gross profit$7.80M$44.60M$109.45M$204.49M$408.72M$714.95M$1.17B$1.73B
Gross margin29.2%54.0%73.6%75.2%77.6%82.0%79.5%73.8%
R&D$11.24M$22.38M$29.24M$48.23M$78.82M$149.30M
SG&A$28.00M$55.86M$54.37M$113.66M$98.19M$129.88M$167.77M$272.72M
Operating income$-75.77M$-74.41M$-15.14M$-115.04M$-68.70M$-29.45M$61.90M$105.61M
Operating margin-284.0%-90.1%-10.2%-42.3%-13.0%-3.4%4.2%4.5%
EBITDA$-71.34M$-14.09M$-110.97M$-61.22M$-19.94M$78.99M$160.12M
EBITDA margin0.0%-86.4%-9.5%-40.8%-11.6%-2.3%5.3%6.8%
EBIT$-75.77M$-71.61M$-15.14M$-115.04M$-68.70M$-29.45M$61.90M$105.61M
Interest expense$0.00$369000.00$10000.00$3.80M$2.99M
Income tax$37000.00$90000.00$127000.00$-3.14M$-31000.00$1.98M$-54.33M
Effective tax rate-0.0%-0.1%-0.7%2.8%0.0%-9.2%-75.8%0.0%
Net income$-75.24M$-72.06M$-18.11M$-107.66M$-65.68M$-23.55M$126.04M$128.37M
Net income growth (YoY)+4.2%+74.9%-494.3%+39.0%+64.1%+635.3%+1.8%
Profit margin-282.0%-87.3%-12.2%-39.6%-12.5%-2.7%8.5%5.5%